Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway

被引:0
作者
Tao Li
Zhiguo Feng
Shaohui Jia
Wei Wang
Zhongxia Du
Ning Chen
Zhengwang Chen
机构
[1] Huazhong University of Science and Technology,Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology
[2] Xinyang Normal University,College of Life Science
[3] The Cancer Institute of New Jersey,undefined
来源
Breast Cancer Research and Treatment | 2012年 / 131卷
关键词
Inflammatory cytokine; Daintain/AIF-1; TNF-α; Breast cancer cell; p38 MAPK; Cell migration;
D O I
暂无
中图分类号
学科分类号
摘要
Tumor-associated macrophages can release a vast diversity of growth factors, proteolytic enzymes, cytokines, and inflammatory mediators. Many of these factors are key agents in cancer metastasis. Daintain/AIF-1 is a macrophage-derived inflammatory cytokine which defined a distinct subset of tumor-associated activated macrophages/microglial cells. Previous study demonstrated that daintain/AIF-1 could promote breast cancer proliferation through activating NF-κB/cyclin D1 pathway and facilitate tumor growth. However, the effect of Daintain/AIF-1 on cell migration and cancer metastasis has never been reported. Herein, we used a mimic tumor microenvironment by incubating breast cancer cell lines, MDA-MB-231 and MCF-7 cells, with macrophage-conditioned medium with or without purified daintain/AIF-1 polypeptide to evaluate cell migration. Results indicated that daintain/AIF-1 enhanced the migration of MDA-MB-231 and MCF-7 cells in the manner of TNF-α up-regulation. Further study found that daintain/AIF-1 activates p38 MAPK signaling pathway contributing to up-regulation of TNF-α in MDA-MB-231 and MCF-7 cells. Therefore, this novel daintain/AIF-1-p38-TNF-α pathway and insight into daintain/AIF-1 might have potential benefits in the control of tumor metastasis during cancer therapy.
引用
收藏
页码:891 / 898
页数:7
相关论文
共 195 条
[1]  
Balkwill F(2005)Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 211-217
[2]  
Charles KA(2001)Inflammation and cancer: back to Virchow? Lancet 357 539-545
[3]  
Mantovani A(2008)Cancer-related inflammation Nature 454 436-444
[4]  
Balkwill F(2008)TNF: a master switch for inflammation to cancer Front Biosci 13 5094-5107
[5]  
Mantovani A(2009)Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability Carcinogenesis 30 1073-1081
[6]  
Mantovani A(2010)Cancer and inflammation: implications for pharmacology and therapeutics Clin Pharmacol Ther 87 401-406
[7]  
Allavena P(2008)Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis Cancer Res 68 1443-1450
[8]  
Sica A(2007)Tumor necrosis factor-α promotes malignant pleural effusion Cancer Research 67 9825-9834
[9]  
Balkwill F(2007)The inflammatory cytokine TNF-α generates an autocrine tumour-promoting network in epithelial ovarian cancer cells Cancer Res 67 585-592
[10]  
Sethi G(1999)Essential role of tumor necrosis factor α (TNF-α) in tumor promotion as revealed by TNF-α-deficient mice Cancer Res 59 4516-4518